Investments Health Insurance Sales Growth Investment Pharmacy Private Equity Pharmaceuticals Applications Financial Performance Corporate Strategy
The healthcare giant cut its 2025 profit forecast, citing surging Medicare Advantage costs, funding reductions, and Optum reimbursement challenges.